Radek
Kaczmarek/LinkedIn; Clive Smith/The Haemophilia Society
Aug 10, 2025, 06:59
WFH Throwback: WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines
World Federation of Hemophilia (WFH) recently shared on LinkedIn:
”Today, the WFH is participating in the WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines (EML).
Radek Kaczmarek, WFH CPSSA Committee Chair, and Clive Smith, WFH Volunteer and President of The Haemophilia Society, delivered a statement outlining critical updates needed to better align the EML with international clinical guidelines for hemophilia and von Willebrand Disease.”
Find the Statement and Call-to-Action presented at WHO Meeting by WFH, ISTH, EAHAD here.
The statement is also endorsed by the following organizations:
- American Society of Gene & Cell Therapy
- Asian-Pacific Society on Thrombosis and Hemostasis
- Association for Haemophilia and Allied Disorders-Asia Pacific
- European Haemophilia Consortium
- European Society for Gene and Cell Therapy
- Grupo Collectivo Latinoamericano de Hemostasis y Trombosis
- National Bleeding Disorders Foundation
Stay informed on the emerging in the field of bleeding disorders with Hemostasis Today.
-
Aug 12, 2025, 18:44Maxime Dely: Does Whole Blood Deserve a Greater Role in Modern Transfusion Medicine?
-
Aug 12, 2025, 18:19Pall T. Onundarson: The Fiix Test Team Was Awarded UNIVANTS 2025!
-
Aug 12, 2025, 14:35Preventable Blood Clots Take Lives: Arshell Shares Her Daughter Leschel’s Tragic Story to Raise Awareness
-
Aug 12, 2025, 14:16Antonio Ciacciarelli: touchNEUROLOGY Future Leader 2025
-
Aug 12, 2025, 06:39Join an NHLBI Clinical Trial on Blood Clots, Inflammation, and Vascular Disease
-
Aug 12, 2025, 17:40Lina Khider: Venous Recanalization of Chronic DVTs Cures Post-Thrombotic Syndrome!
-
Aug 12, 2025, 11:08A Rare Case of Aortic Thrombosis in a Newborn With CDH
-
Aug 12, 2025, 03:37Low-Intensity DOACs in VTE: Sapienza University Reports Long-Term Outcomes
-
Aug 12, 2025, 02:00Arsene Mekinian։ International Vexas' Announcements Is Finally Published
-
Aug 12, 2025, 01:27Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
Aug 12, 2025, 18:19
Aug 12, 2025, 17:05
Aug 12, 2025, 16:01
Aug 12, 2025, 14:16
Aug 12, 2025, 11:08
Aug 12, 2025, 03:37
Aug 12, 2025, 02:00
Aug 12, 2025, 01:27